UK-South Africa TB Diagnostics study

View transcript

Tuberculosis (TB) is a leading cause of death in South Africa, killing over 60,000 people in 2020. New technologies have the potential to speed up diagnosis and treatment, cut TB transmission and improve patient care. But these life-saving innovations have not yet been implemented effectively in the places that need them most. Under South Africa’s National Priority Programmes, a team of researchers have been working together to evaluate and advance several new technologies that will help the country deliver accurate, affordable, and accessible TB diagnostic services and patient care.

Find out more about the study -

Newton Fund and GCRF are drawing to a close. The International Science Partnerships Fund (ISPF) is a new UK Government fund supporting research and innovation on the major themes of our time: Planet, Health, Tech, Talent. To stay on the Newton-GCRF website click Continue, if you would like to find out more about ISPF click Read more.